Hantech Bio-Technology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	178.96	148.12	47.47
Depreciation & Amortization	25.45	19.44	18.86
Other Amortization	1.65	1.5	0.47
Loss (Gain) From Sale of Assets	0.46	0.11	0.55
Stock-Based Compensation	0.15	0.05	0.17
Provision & Write-off of Bad Debts	-0.08	-0.56	0.61
Other Operating Activities	12.3	20.99	7.75
Change in Accounts Receivable	-61.54	-37.82	-25.73
Change in Inventory	-62.75	-50.08	-9.72
Change in Accounts Payable	21.45	65.47	20.05
Change in Other Net Operating Assets	28.41	24.68	2.69
Operating Cash Flow	144.46	191.91	63.18
Operating Cash Flow Growth	-	203.76%	-
Capital Expenditures	-272.07	-293.94	-82.88
Sale of Property, Plant & Equipment	0.02	1.83	0.11
Sale (Purchase) of Intangibles	-0.03	-3.28	-0.74
Investment in Securities	-9.15	-1.2	-
Other Investing Activities	0.02	0.96	-0.57
Investing Cash Flow	-281.22	-295.63	-84.07
Short-Term Debt Issued	-	9	10
Long-Term Debt Issued	-	269.32	26.34
Total Debt Issued	236.75	278.32	36.34
Short-Term Debt Repaid	-	-10	-13
Long-Term Debt Repaid	-	-57.72	-58.45
Total Debt Repaid	-72.03	-67.72	-71.45
Net Debt Issued (Repaid)	164.72	210.6	-35.11
Issuance of Common Stock	0.64	2.07	44.63
Common Dividends Paid	-16.84	-16.84	-
Financing Cash Flow	148.52	195.83	9.52
Foreign Exchange Rate Adjustments	0.31	-0.05	0
Net Cash Flow	12.07	92.05	-11.37
Free Cash Flow	-127.61	-102.03	-19.7
Free Cash Flow Margin	-16.47%	-16.32%	-6.51%
Free Cash Flow Per Share	-4.92	-3.98	-0.83
Cash Interest Paid	2.81	1.42	0.31
Cash Income Tax Paid	35.62	15.49	5.13
Levered Free Cash Flow	-	-139.37	-
Unlevered Free Cash Flow	-	-138.05	-
Change in Net Working Capital	-	-22.11	-

Source: S&P Capital IQ. Standard template. Financial Sources.